Phytohealth Corp (4108) - Total Assets

Latest as of December 2025: NT$2.35 Billion TWD ≈ $74.13 Million USD

Based on the latest financial reports, Phytohealth Corp (4108) holds total assets worth NT$2.35 Billion TWD (≈ $74.13 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 4108 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Phytohealth Corp - Total Assets Trend (2002–2025)

This chart illustrates how Phytohealth Corp's total assets have evolved over time, based on quarterly financial data. See Phytohealth Corp (4108) net assets for net asset value and shareholders' equity analysis.

Phytohealth Corp - Asset Composition Analysis

Current Asset Composition (December 2025)

Phytohealth Corp's total assets of NT$2.35 Billion consist of 53.7% current assets and 46.3% non-current assets.

Asset Category Amount (TWD) % of Total Assets
Cash & Equivalents NT$0.00 3.7%
Accounts Receivable NT$36.36 Million 1.6%
Inventory NT$126.08 Million 5.4%
Property, Plant & Equipment NT$0.00 0.0%
Intangible Assets NT$28.83 Million 1.2%
Goodwill NT$31.18 Million 1.3%

Asset Composition Trend (2002–2025)

This chart illustrates how Phytohealth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Phytohealth Corp market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Phytohealth Corp's current assets represent 53.7% of total assets in 2025, an increase from 0.0% in 2002.
  • Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, down from 27.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2002.
  • Asset Diversification: The largest asset category is inventory at 5.4% of total assets.

Phytohealth Corp Competitors by Total Assets

Key competitors of Phytohealth Corp based on total assets are shown below.

Company Country Total Assets
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
China CN¥11.59 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
China CN¥10.21 Billion
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
China CN¥17.01 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥13.81 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
China CN¥6.56 Billion
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
China CN¥5.91 Billion
KPC Pharmaceuticals Inc
SHG:600422
China CN¥12.01 Billion

Phytohealth Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 27.41 24.02 22.31
Quick Ratio 24.67 21.15 20.18
Cash Ratio 0.00 0.00 0.00
Working Capital NT$1.22 Billion NT$1.25 Billion NT$1.58 Billion

Phytohealth Corp - Advanced Valuation Insights

This section examines the relationship between Phytohealth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.28
Latest Market Cap to Assets Ratio 0.03
Asset Growth Rate (YoY) -3.5%
Total Assets NT$2.35 Billion
Market Capitalization $73.21 Million USD

Valuation Analysis

Below Book Valuation: The market values Phytohealth Corp's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Phytohealth Corp's assets decreased by 3.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Phytohealth Corp (2002–2025)

The table below shows the annual total assets of Phytohealth Corp from 2002 to 2025.

Year Total Assets Change
2025-12-31 NT$2.35 Billion
≈ $74.13 Million
-3.55%
2024-12-31 NT$2.44 Billion
≈ $76.86 Million
+3.79%
2023-12-31 NT$2.35 Billion
≈ $74.05 Million
-0.60%
2022-12-31 NT$2.36 Billion
≈ $74.50 Million
-4.27%
2021-12-31 NT$2.47 Billion
≈ $77.82 Million
+36.50%
2020-12-31 NT$1.81 Billion
≈ $57.01 Million
-3.84%
2019-12-31 NT$1.88 Billion
≈ $59.29 Million
-9.01%
2018-12-31 NT$2.07 Billion
≈ $65.16 Million
-5.65%
2017-12-31 NT$2.19 Billion
≈ $69.07 Million
-9.60%
2016-12-31 NT$2.42 Billion
≈ $76.40 Million
+3.64%
2015-12-31 NT$2.34 Billion
≈ $73.72 Million
-6.00%
2014-12-31 NT$2.49 Billion
≈ $78.42 Million
-11.85%
2013-12-31 NT$2.82 Billion
≈ $88.97 Million
-2.06%
2012-12-31 NT$2.88 Billion
≈ $90.84 Million
+74.70%
2011-12-31 NT$1.65 Billion
≈ $52.00 Million
-13.45%
2010-12-31 NT$1.91 Billion
≈ $60.08 Million
-9.79%
2009-12-31 NT$2.11 Billion
≈ $66.60 Million
+96.20%
2008-12-31 NT$1.08 Billion
≈ $33.94 Million
-30.74%
2007-12-31 NT$1.56 Billion
≈ $49.01 Million
+15.04%
2006-12-31 NT$1.35 Billion
≈ $42.60 Million
+11.66%
2005-12-31 NT$1.21 Billion
≈ $38.15 Million
+296.80%
2004-12-31 NT$305.18 Million
≈ $9.61 Million
-11.31%
2003-12-31 NT$344.09 Million
≈ $10.84 Million
+120.54%
2002-12-31 NT$156.02 Million
≈ $4.92 Million
--

About Phytohealth Corp

TW:4108 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$73.21 Million
NT$2.32 Billion TWD
Market Cap Rank
#20395 Global
#1210 in Taiwan
Share Price
NT$11.70
Change (1 day)
+0.43%
52-Week Range
NT$11.55 - NT$17.30
All Time High
NT$46.36
About

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more